Language discordance as a marker of disparities in cerebrovascular risk and stroke outcomes: A multi-center Canadian study.

Cognitive impairment Depression Language concordance Obstructive sleep apnea Stroke Transient ischemic attack Vascular risk factors

Journal

Cerebral circulation - cognition and behavior
ISSN: 2666-2450
Titre abrégé: Cereb Circ Cogn Behav
Pays: Netherlands
ID NLM: 101774849

Informations de publication

Date de publication:
2023
Historique:
received: 15 08 2022
revised: 04 02 2023
accepted: 16 02 2023
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

Differences in ischemic stroke outcomes occur in those with limited English proficiency. These health disparities might arise when a patient's spoken language is discordant from the primary language utilized by the health system. Language concordance is an understudied concept. We examined whether language concordance is associated with differences in vascular risk or post-stroke functional outcomes, depression, obstructive sleep apnea and cognitive impairment. This was a multi-center observational cross-sectional cohort study. Patients with ischemic stroke/transient ischemic attack (TIA) were consecutively recruited across eight regional stroke centers in Ontario, Canada (2012 - 2018). Participants were language concordant (LC) if they spoke English as their native language, ESL if they used English as a second language, or language discordant (LD) if non-English speaking and requiring translation. 8156 screened patients. 6,556 met inclusion criteria: 5067 LC, 1207 ESL and 282 LD. Compared to LC patients: (i) ESL had increased odds of diabetes (OR = 1.28, Measuring language concordance in stroke/TIA reveals differences in neurovascular risk and functional outcome among patients with limited proficiency in the primary language of their health system. Lower cognitive scores must be interpreted with caution as they may be influenced by translation and/or greater vascular risk. Language concordance is a simple, readily available marker to identify those at risk of worse functional outcome. Stroke systems and practitioners must now study why these differences exist and devise adaptive care models, treatments and education strategies to mitigate barriers influenced by language discordance.

Sections du résumé

Background UNASSIGNED
Differences in ischemic stroke outcomes occur in those with limited English proficiency. These health disparities might arise when a patient's spoken language is discordant from the primary language utilized by the health system. Language concordance is an understudied concept. We examined whether language concordance is associated with differences in vascular risk or post-stroke functional outcomes, depression, obstructive sleep apnea and cognitive impairment.
Methods UNASSIGNED
This was a multi-center observational cross-sectional cohort study. Patients with ischemic stroke/transient ischemic attack (TIA) were consecutively recruited across eight regional stroke centers in Ontario, Canada (2012 - 2018). Participants were language concordant (LC) if they spoke English as their native language, ESL if they used English as a second language, or language discordant (LD) if non-English speaking and requiring translation.
Results UNASSIGNED
8156 screened patients. 6,556 met inclusion criteria: 5067 LC, 1207 ESL and 282 LD. Compared to LC patients: (i) ESL had increased odds of diabetes (OR = 1.28,
Conclusions UNASSIGNED
Measuring language concordance in stroke/TIA reveals differences in neurovascular risk and functional outcome among patients with limited proficiency in the primary language of their health system. Lower cognitive scores must be interpreted with caution as they may be influenced by translation and/or greater vascular risk. Language concordance is a simple, readily available marker to identify those at risk of worse functional outcome. Stroke systems and practitioners must now study why these differences exist and devise adaptive care models, treatments and education strategies to mitigate barriers influenced by language discordance.

Identifiants

pubmed: 36909680
doi: 10.1016/j.cccb.2023.100163
pii: S2666-2450(23)00007-7
pmc: PMC9996323
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100163

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

None.

Références

J Am Heart Assoc. 2013 Jul 05;2(4):e000170
pubmed: 23832325
Stroke. 2015 Mar;46(3):813-8
pubmed: 25657184
Brain Inj. 2017;31(2):140-150
pubmed: 27740867
J Health Psychol. 2012 Apr;17(3):443-52
pubmed: 21900335
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Acta Neurol Taiwan. 2011 Jun;20(2):77-84
pubmed: 21739386
J Gen Intern Med. 2013 May;28(5):675-82
pubmed: 23288379
Chest. 2016 Mar;149(3):631-8
pubmed: 26378880
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Neuroepidemiology. 2005;24(1-2):79-86
pubmed: 15459514
J Geriatr Psychiatry Neurol. 2019 Jan;32(1):40-48
pubmed: 30793663
JAMA. 2019 Oct 22;322(16):1605-1607
pubmed: 31638666
Stroke. 2008 Oct;39(10):2736-43
pubmed: 18635860
Stroke. 2006 Sep;37(9):2220-41
pubmed: 16917086
Stroke. 2010 May;41(5):905-9
pubmed: 20339124
Int J Qual Health Care. 2007 Apr;19(2):60-7
pubmed: 17277013
Neurology. 2012 Sep 18;79(12):1200-7
pubmed: 22895592
Int J Stroke. 2016 Jul;11(5):509-18
pubmed: 27073189
BMC Health Serv Res. 2013 Aug 16;13:319
pubmed: 23958036
Stroke. 2012 Apr;43(4):1186-91
pubmed: 22363052
PLoS One. 2017 Apr 4;12(4):e0174451
pubmed: 28376127
Med Care. 2012 Apr;50(4):283-9
pubmed: 22411441
Stroke. 2020 May;51(5):1555-1562
pubmed: 32279618

Auteurs

Ryan T Muir (RT)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Arunima Kapoor (A)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Megan L Cayley (ML)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Michelle N Sicard (MN)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Karen Lien (K)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Alisia Southwell (A)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Dar Dowlatshahi (D)

Ottawa Stroke Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Demetrios J Sahlas (DJ)

McMaster University, Department of Medicine (Neurology), Hamilton General Hospital, Hamilton Health Sciences, Hamilton, ON, Canada.

Gustavo Saposnik (G)

St. Michael's Hospital, Division of Neurology, Toronto, ON, Canada.

Jennifer Mandzia (J)

London Health Sciences Centre, Division of Neurology, London, ON, Canada.

Leanne K Casaubon (LK)

University Health Network/Toronto Western Hospital, Division of Neurology, Toronto, ON, Canada.

Ayman Hassan (A)

Thunder Bay Regional Health Sciences Centre, Division of Neurology, Thunder Bay, ON, Canada.

Yael Perez (Y)

Trillium Health Partners, Department of Medicine (Neurology), Mississauga, ON, Canada.

Daniel Selchen (D)

St. Michael's Hospital, Division of Neurology, Toronto, ON, Canada.

Brian J Murray (BJ)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Sunnybrook Research Institute, Toronto, ON, Canada.

Krista Lanctot (K)

Sunnybrook Research Institute, Toronto, ON, Canada.
University of Toronto, Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON Canada.

Moira K Kapral (MK)

Sunnybrook Research Institute, Toronto, ON, Canada.
University of Toronto, Department of Medicine, Division of General Internal Medicine, Toronto, Canada.
ICES, Toronto, ON, Canada.
University of Toronto, Institute of Health Policy Management and Evaluation, Toronto, ON, Canada.

Nathan Herrmann (N)

Sunnybrook Research Institute, Toronto, ON, Canada.
University of Toronto, Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON Canada.

Stephen Strother (S)

Rotman Research Institute, Centre for Stroke Recovery, Baycrest Site, Toronto, ON, Canada.

Amy Y X Yu (AYX)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Sunnybrook Research Institute, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.
University of Toronto, Institute of Health Policy Management and Evaluation, Toronto, ON, Canada.

Peter C Austin (PC)

ICES, Toronto, ON, Canada.
University of Toronto, Institute of Health Policy Management and Evaluation, Toronto, ON, Canada.

Susan E Bronskill (SE)

Sunnybrook Research Institute, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.
University of Toronto, Institute of Health Policy Management and Evaluation, Toronto, ON, Canada.

Richard H Swartz (RH)

University of Toronto, Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Sunnybrook Research Institute, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.

Classifications MeSH